Table 3. Multivariate analysis for progression-free survival and overall survival in 44 cases with stages II–IV ovarian clear cell carcinomas.
| |
|
Progression-free survival |
Overall survival |
||||
|---|---|---|---|---|---|---|---|
| Variables | Hazard ratio (95% CI) | P-value | Hazard ratio (95% CI) | P-value | |||
| Age |
⩽50 vs >50 |
0.75 |
(0.32–1.76) |
0.51 |
0.55 |
(0.20–1.48) |
0.23 |
| WHO performance status |
0/1 vs ⩾2 |
0.74 |
(0.14–3.79) |
0.71 |
0.58 |
(0.11–2.95) |
0.51 |
| FIGO stage |
II vs III/IV |
0.58 |
(0.19–1.77) |
0.37 |
0.60 |
(0.16–2.22) |
0.44 |
| Residual tumour diameter |
>1 cm vs ⩽1 cm |
3.48 |
(1.40–8.62) |
<0.01 |
5.35 |
(1.98–15.0) |
<0.01 |
| XIAP expression | High vs low | 2.94 | (1.22–7.09) | 0.02 | 2.70 | (1.02–7.16) | 0.04 |
Abbreviations: CI=confidence interval; FIGO=International Federation of Obstetrics and Gynecology; WHO=World Health Organisation; XIAP=X-chromosome-linked inhibitor of apoptosis.